SFX by Ex Libris Inc.

Title:	Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses
Source:	Human Molecular Genetics [0964-6906] Sipione, S yr:2015

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Hodges, A. "Brain gene expression correlates with changes in behavior in the R6/1 mouse model of Huntington's disease." Genes, brain, and behavior 7.3 (2008): 288-299.
description	2.	Orr, Harry T. "Microarrays and polyglutamine disorders: reports from the Hereditary Disease Array Group." Human molecular genetics 11.17 (2002): 1909-10.
description	3.	Schiffer, D. "Repressor element-1 silencing transcription factor (REST) is present in human control and Huntington's disease neurones." Neuropathology & applied neurobiology 40.7 (2014): 899-910.
description	4.	Slow, Elizabeth J. "Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease." Human Molecular Genetics 12.13 (2003): 1555-1567.
description	5.	Steffan J S, J S S. "Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila." Nature 413.6857 (2001): 739-43.
description	6.	Bates, G P P. "Huntington's disease. Exploiting expression." Nature 413.6857 (2001): 691-4.
description	7.	Hoshino, M. "Histone deacetylase activity is retained in primary neurons expressing mutant huntingtin protein." Journal of neurochemistry 87.1 (2003): 257-267.
description	8.	Woodman, B. "The Hdh(Q150 Q150) knock-in mouse model of HD and the R6 2 exon 1 model develop comparable and widespread molecular phenotypes." Brain Research Bulletin 72.2-3 (2007): 83-97.
description	9.	Heng, Mary Y Y. "Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington's disease." The journal of neuroscience 27.34 (2007): 8989-98.
description	10.	Adel Tabchy David Housman, A. "Huntington's disease: A transcriptional report card from the peripheral blood: can it measure disease progression in Huntington's disease?" European journal of human genetics 14.6: 649-50.
description	11.	Gonitel, R. "DNA instability in postmitotic neurons." Proceedings of the National Academy of Sciences of the United States of America 105.9 (2008): 3467-3472.
description	12.	Hackl, H. "Analysis of DNA microarray data." Current topics in medicinal chemistry 4.13 (2004): 1357-1370.
description	13.	Cha, Jang-Ho J J. "Transcriptional signatures in Huntington's disease." Progress in Neurobiology 83.4 (2007): 228-248.
description	14.	Mangiarini, L. "Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice." Cell 87.3 (1996): 493-506.
description	15.	Li, P. "An Effective Method to Identify Shared Pathways and Common Factors among Neurodegenerative Diseases." PLoS One 10.11 (2015).
description	16.	Giampà, C. "Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6/2 mouse model of Huntington's disease." PLoS ONE 8.6 (2013).
description	17.	Frich, Merete C. "Caregiver roles in families affected by Huntington's disease: a qualitative interview study." Scandinavian journal of caring sciences 28.4 (2013): 700-705.
description	18.	Sipione, S. "Impaired Ganglioside Metabolism in Huntington's Disease and Neuroprotective Role of GM1." The journal of neuroscience 30.11 (2010): 4072-4080.
description	19.	Schoenherr, C. "The neuron-restrictive silencer factor (NRSF): A coordinate repressor of multiple neuron-specific genes." Science 267.5202 (1995): 1360-1363.
description	20.	Butler, R. "Histone deacetylase inhibitors as therapeutics for polyglutamine disorders." Nature reviews. Neuroscience 7.10 (2006): 784-796.